Cerus Corporation (NASDAQ:CERS) will be hosting a conference call at 4:30 PM eastern time on 29th October 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.cerus.com
Earnings Expectation
Cerus Corporation is set to announce third quarter earning results on Thursday 29th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, CERS to report 3Q20 loss of $ 0.1 per share. For the full year, analysts anticipate top line of $ 112.46 million, while looking forward to loss of $ 0.4 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 89.00 million ~ $ 93.00 million
Click Here For More Historical Outlooks Of Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion.
